Naproxen Tablet
Product Images NDC 42494-454

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Naproxen (NDC 42494-454). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cameron Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Naproxen 01)

Chemical structure of naproxen (C14H14O3), showing the molecular formula and a depiction of its aromatic rings, methoxy group, and carboxyl functional group represented by R=COOH.*

FDA Label Image

Principal Display Panel (375 mg Tablet Bottle Label)

Naproxen Delayed-release Tablets, USP 375 mg label for 100 oral tablets. The label includes the drug name, strength, dosage form, quantities, and patient medication guide instruction. It also shows storage instructions, distributor Cameron Pharmaceuticals contact information, and a barcode.*

FDA Label Image

Principal Display Panel (500 mg Tablet Bottle Label)

Naproxen Delayed-release Tablets, USP 500 mg oral tablets label. The label shows a bottle containing 100 tablets and includes dosing information, storage instructions (20° to 25°C), child-resistant packaging notice, and distributor details for Cameron Pharmaceuticals, LLC. The label features a barcode and Rx only designation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.